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Abstract
Background: White matter injury is the major form of brain damage in very preterm infants. Selective white matter
injury in the immature brain can be induced by lipopolysaccharide (LPS)-sensitized hypoxic-ischemia (HI) in the
postpartum (P) day 2 rat pups whose brain maturation status is equivalent to that in preterm infants less than
30 weeks of gestation. Neuroinflammation, blood–brain barrier (BBB) damage and oligodendrocyte progenitor
apoptosis may affect the susceptibility of LPS-sensitized HI in white matter injury. c-Jun N-terminal kinases (JNK) are
important stress-responsive kinases in various forms of insults. We hypothesized that LPS-sensitized HI causes white
matter injury through JNK activation-mediated neuroinflammation, BBB leakage and oligodendroglial apoptosis in
the white matter of P2 rat pups.
Methods: P2 pups received LPS (0.05 mg/kg) or normal saline injection followed by 90-min HI.
Immunohistochemistry and immunoblotting were used to determine microglia activation, TNF-α, BBB damage,
cleaved caspase-3, JNK and phospho-JNK (p-JNK), myelin basic protein (MBP), and glial fibrillary acidic protein
(GFAP) expression. Immunofluorescence was performed to determine the cellular distribution of p-JNK.
Pharmacological and genetic approaches were used to inhibit JNK activity.
Results: P2 pups had selective white matter injury associated with upregulation of activated microglia, TNF-α, IgG
extravasation and oligodendroglial progenitor apoptosis after LPS-sensitized HI. Immunohistochemical analyses
showed early and sustained JNK activation in the white matter at 6 and 24 h post-insult. Immunofluorescence
demonstrated upregulation of p-JNK in activated microglia, vascular endothelial cells and oligodendrocyte
progenitors, and also showed perivascular aggregation of p-JNK-positive cells around the vessels 24 h post-insult.
JNK inhibition by AS601245 or by antisense oligodeoxynucleotides (ODN) significantly reduced microglial activation,
TNF-α immunoreactivity, IgG extravasation, and cleaved caspase-3 in the endothelial cells and oligodendrocyte
progenitors, and also attenuated perivascular aggregation of p-JNK-positive cells 24 h post-insult. The AS601245 or
JNK antisense ODN group had significantly increased MBP and decreased GFAP expression in the white matter on
P11 than the vehicle or scrambled ODN group.
Conclusions: LPS-sensitized HI causes white matter injury through JNK activation-mediated upregulation of
neuroinflammation, BBB leakage and oligodendrocyte progenitor apoptosis in the immature brain.
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Background
Spastic cerebral palsy develops in 5 to 10% of the survivors
among very preterm infants (less than 32 weeks of gesta-
tion age) [1,2]. Cerebral white matter injury is the major
form of brain injury and the leading cause of cerebral
palsy in children who are born very prematurely [1,2]. The
neuropathologic hallmark of white matter injury in pre-
term infants includes a multitude of activated microglia
and macrophages that produce pro-inflammatory cyto-
kines at early stage, and focal and diffuse white matter
lesions along with astrocytosis and hypomyelination at late
stage [1,2].
Epidemiological observations show that hypoxic-
ischemia (HI) and infection are the two major risk fac-
tors of white matter injury and cerebral palsy in very
preterm infants [3-5]. Clinical studies have implicated
the potentiating effect of infection on HI in preterm
infants [6-8]. Animal studies have also shown that pre-
exposure to systemic lipopolysaccharide (LPS) sensitized
HI injury in the cerebral cortex and white matter of
postpartum (P) day 7 or 8 rodent pups, where brain
maturation status is equivalent to 32 to 34 weeks of ges-
tation of preterm infants [9-11]. The O4-positive oligo-
dendrocyte progenitors are the target cells of damage
during the window of vulnerability for white matter in-
jury in premature infants at 23 to 32 weeks of gestation
[12]. Comparing the timing of human and rodent oligo-
dendroglial lineage progression, the predominance of
pre-myelinating oligodendrocytes in P2 rat pups (brain
maturation status equivalent to very preterm infants less
than 30 weeks) coincides with the high-risk period of
white matter injury in very preterm infants [13]. Our
previous study in P2 rat pups demonstrated that LPS or
90-minute HI (a sub-threshold duration for P2 pups)
alone caused no significant injury in the cortex or white
matter, whereas selective white matter injury could only
be induced by the combination of the two [14]. The
findings suggest that LPS sensitizes HI, and selectively
causes white matter injury in the immature brain.
The major target of ischemic-reperfusion injury in the
cerebral cortex is the neurovascular unit, which is com-
posed of neurons, microglia and microvessels [15].
Neuronal apoptosis, microglia activation and micro-
vascular damage, in other words blood–brain barrier
(BBB) disruption, have been linked with the severity of
HI cortical neuronal injury in P7 to P10 rat pups [16-
19]. Similar to the framework of the “neurovascular unit”
in the cerebral cortex [15], microglia, oligodendrocyte
progenitors and microvascular endothelial cells may
form a closely inter-related “oligodendrovascular unit” in
the white matter, which may be the major target of white
matter injury in the preterm infants. During detrimental
insults in the immature brain, activated microglia may
exacerbate white matter injury through production of
pro-inflammatory cytokines, such as TNF-α [1,20]. The
damaged microvessels may recruit activated leukocytes
into the injured white matter through the disrupted
BBB, resulting in sustained activation of microglia, which
in turn further damage the white matter through pro-
longed production of inflammatory cytokines [21]. Since
microglia, vascular endothelial cells and oligodendro-
cytes may closely interact with each other in the white
matter, there may be a common signaling mechanism
linking neuroinflammation, BBB disruption and oligo-
dendroglial progenitor cell apoptosis in the white matter
injury of the immature brain.
c-Jun N-terminal kinases (JNK) are important stress-
responsive kinases that are activated by various forms of
insults, including ischemia [22]. JNK activation precedes
cell death by inflammation and apoptosis in many cell
types [23]. Activation of JNK signaling leads not only to
pro-inflammatory cytokine production, but also to cell
death via intrinsic/extrinsic apoptotic pathways [22,24-28].
In vitro studies show that JNK signaling is the predom-
inant pathway for cytokine production from LPS-
stimulated or hypoxia-exposed microglia [29,30]. JNK
signaling also plays a crucial role in subarachnoid
hemorrhage-associated BBB disruption, and stress-
induced apoptosis of cerebral endothelial cells and
oligodendrocyte progenitors [31-33]. In vivo studies
demonstrated early and lasting JNK activation after cere-
bral ischemia [34,35]. Our previous study in P7 rat pups
showed that neonatal overweight increased HI-induced
neuronal apoptosis, microglial activation and BBB dam-
age in the cerebral cortex, and aggravated cortical dam-
age through JNK hyperactivation [18]. However, it
remains unclear whether JNK activation is the common
pathogenic mechanism in the “oligodendrovascular unit”
leading to white matter damage in the immature brain
of P2 rat pups.
Using an established model of LPS-sensitized HI white
matter injury in P2 rat pups [14], we hypothesized that
JNK signaling is the shared pathway linking neuroin-
flammation, microvascular endothelial cell damage and
BBB breakdown, and apoptosis of oligodendroglial pre-
cursor cells in the white matter injury of the immature
brain.
Methods
A selective white matter injury model in P2 rat pups
induced by lipopolysaccharide-sensitized hypoxic-
ischemia
The animal study was approved by the Animal Care
Committee at National Cheng Kung University. Spra-
gue–Dawley rat pups were housed under standard con-
dition with a 12/12-h light/dark cycle. We first injected
P2 rat pups intraperitoneally with 0.05 mg/kg LPS
(Escherichia coli 0111:B4; Sigma-Aldrich, St Louis, MO,
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USA) or pyrogen-free normal saline (NS). Neuropatho-
logical examinations performed on P11 showed that,
compared with the NS-treated group, the LPS-treated
pups had no significant injury in the cortex (Additional
file 1: Figure 1A) and white matter (Additional file 1:
Figure 1B). The LPS-treated pups also showed no evi-
dence of microglial activation and BBB breakdown in
the white matter (Additional file 1: Figure 1C). These
findings suggested low-dose LPS did not cause damage
in the cortex or upregulate neuroinflammation and BBB
disruption in the white matter of P2 rat pups.
We then injected P2 pups with LPS (0.05 mg/kg) or NS
3 h before HI, as described previously [14]. Pups were
randomly assigned to three different groups: control (NS
without HI), NS +HI (NS injected 3 h before HI), and
LPS +HI (LPS injected 3 h before HI). To avoid LPS-
induced body temperature changes, the rat pups were
returned to their dams after injection, and housed in an
incubator to maintain body temperature at 33 to 34 °C
before HI. HI was then induced by ligation of the right
carotid artery followed by hypoxia [36]. The right com-
mon carotid artery was permanently ligated under 2.5%
halothane anesthesia. After surgery, the pups were
returned to an incubator for a 1-h recovery. They were
then placed in airtight 500 mL containers partially sub-
merged in a 36 °C water bath, and humidified 6.5% oxy-
gen was kept at a flow rate of 3 L/minute for 90 minutes.
Following hypoxia, pups were returned to their dam.
Pharmacological inhibition of JNK
AS601245, a highly specific JNK inhibitor, blocks JNK
activity by binding to its ATP-binding site [37]. The P2
pups were randomly assigned to three different groups:
(1) control group without being exposed to LPS +HI; (2)
intraperitoneal injection of vehicle (DMSO, Sigma-
Aldrich) 30 minutes before and immediately after LPS +
HI; and (3) intraperitoneal injection of AS601245 20 or
40 mg/kg (Alexis Biochemicals, Lausen, Switzerland) 30
minutes before and immediately after LPS +HI. The
dose of AS601245 used in this study was modified from
the study by Carboni and colleagues [37].
Knockdown of JNK gene expression by antisense
oligodeoxynucleotides
P2 pups were intracerebroventricularly infused with JNK
antisense or scrambled oligodeoxynucleotides (ODN)
into the right cerebral hemisphere using a 30-gauge nee-
dle on a 10 μL Hamilton syringe with an infusion rate of
1 μL/minute, as previously described [38]. The injection
location was 2.0 mm posterior to and 1.5 mm lateral to
the bregma and 2.0 mm beneath the skull surface. The
first ODN (100 pmol in 1 μL) were injected 30 minutes
before LPS +HI, and the second ODN (100 pmol in 1
μL) given immediately after LPS +HI. The sequences of
the JNK antisense were 5’-TTT CTT CAT GAA YTC-3’,
and the scrambled ODNs were 5’-GTC TTG AAC TTC
CCG -3’. Based on the mRNA sequences for rat JNK iso-
forms (Genebank accession number JNK1, XM_341399;
JNK2, NM_017322; JNK3, NM_012806), the antisense
sequence matched the rat JNK1-3 cDNA sequences,
while the scrambled ODN showed no significant
matches. The pups that were not exposed to LPS +HI
served as the control group. The white matter tissues
were collected for Western blot analyses at 3, 6 and 12 h
after the second ODN injection.
Western blot analysis
The temporal profile of JNK activation after LPS +HI
was assessed using Western blot analysis. Ipsilateral
cerebral white matter tissues were homogenized in cold
lysis buffer, and the protein concentrations determined
using a Bio-Rad Protein Assay kit (Bio-Rad Laboratories,
Hercules, CA, USA). Samples (50 μg) were separated
using 10% SDS-PAGE and blotted onto polyvinylidene
fluoride membranes. Membranes were incubated with
primary antibodies, and immunoreactivity was detected
by horseradish-conjugated secondary antibody and
visualized using enhanced chemiluminescence. The fol-
lowing primary antibodies were used: anti-JNK (1:1000;
Cell Signaling, Danvers, MA, USA), anti-phospho-JNK
(Thr183/Tyr185) (1:1000; Cell Signaling), and anti-actin
(1:5000; Millipore, Billerica, MA, USA). Western blot
signals were quantified by scanning with a ScanJet scan-
ner (Hewlett Packard, Palo Alto, CA, USA), and the
band intensity was analyzed using an imaging software
(ImagePro Plus 6.0; Media Cybernetics, Bethesda, MD,
USA).
In vitro kinase assay for JNK activity
We compared JNK activity between the vehicle-treated
and AS601245-treated pups at 6 and 24 h post-insult.
JNK activity was measured using a specific kit (Cell Sig-
naling), and glutathione S-transferase-Jun (1–79) fusion
peptides served as the substrate for JNK as previously
described [18]. In brief, white matter tissue lysates
(200 μg) were incubated overnight at 4 °C with glutathi-
one S-transferase-Jun fusion protein beads. After wash-
ing, the beads were resuspended in kinase buffer
containing ATP, and the kinase reaction was allowed to
continue for 30 minutes at 30 °C. Reactions were
stopped by adding polyacrylamide gel electrophoresis
sample loading buffer. Proteins were separated by elec-
trophoresis on 10% SDS-PAGE, transferred onto polyvi-
nylidene fluoride membrane, and incubated with
phospho-c-Jun (Ser63) antibody (1:1000; Cell Signaling).
Immunoreactivity was detected using enhanced chemilu-
minescence (Amersham, Piscataway, NJ, USA).
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Immunohistochemistry
The pups were sacrificed and perfused for cryosections at
6 and 24 h post-insult on P2. The brains were post-fixed
in ice-cold 4% paraformaldehyde overnight, dehydrated
using 30% (w/v) sucrose in PBS for 2 days, and coronally
sectioned (20-μm thick) from the genu of the corpus cal-
losum to the end of the dorsal hippocampus. Four coronal
sections, two at the level of the striatum (0.26 mm and
0.92 mm posterior to the bregma) and another two at the
levels of the dorsal hippocampus (3.14 mm and 4.16 mm
posterior to the bregma) selected according to a rat brain
atlas [39], were assessed for each brain.
Immunohistochemistry for phospho-JNK (p-JNK) was
performed at 6 h and 24 h post-insult, while staining for
microglial activation, TNF-α, IgG, and cleaved caspase 3
was performed at 24 h post-insult. IgG extravasation
was used as an indicator of BBB permeability [40]. The
specific primary antibodies used included rabbit poly-
clonal anti-p-JNK (1:100; Cell Signaling), mouse anti-rat
ED1 (microglia marker; 1:100; Millipore), rabbit poly-
clonal anti-rat TNF-α (1:100; Bender MedSystems, Vi-
enna, Austria), horseradish peroxidase-conjugated goat
anti-rat IgG (1:200; Millipore) and rabbit polyclonal
anti-cleaved caspase 3 (1:100; Cell Signaling). Biotiny-
lated secondary antibodies included anti-mouse IgG and
anti-rabbit IgG (all 1:200; Pierce Biotechnology, Rock-
ford, IL, USA). Biotin-peroxidase signals were detected
using 0.5 mg/mL 3’3’-diaminobenzidine (DAB)/0.003%
H2O2 (Dako, Carpinteria, CA, USA) as a substrate.
Results were recorded using a microscope (BX51; Olym-
pus, Tokyo, Japan).
Assessment for white matter injury
The brains were prepared in paraffin sections for patho-
logical examinations on P11. The brains were removed and
post-fixed in 4% paraformaldehyde at room temperature
for 48 h, dehydrated through graded alcohols and embed-
ded in paraffin, and then coronally sectioned (10-μm thick)
from the genu of the corpus callosum to the end of the
dorsal hippocampus. Myelin basic protein (MBP) staining
for myelination and glial fibrillary acidic protein (GFAP)
staining for astrogliosis in the white matter were used as
markers of white matter injury. Four coronal sections, two
at the level of the striatum (0.26 mm and 0.92 mm poster-
ior to the bregma) and another two at the level of the dor-
sal hippocampus (3.14 mm and 4.16 mm posterior to the
bregma) according to a rat brain atlas [39], were assessed
for each brain. Paraffin-embedded sections were deparaffi-
nized and hydrated through graded alcohols. Endogenous
peroxidases were eradicated for 30 minutes in 0.3% H2O2
in methanol. Heat-induced antigen retrieval was subse-
quently performed using 10 nmol/L citrate buffer (pH=
6.0) for 10 minutes in a microwave oven. After permeali-
zation and blocking of non-specific binding, sections
were first incubated at 4 °C overnight with rat anti- MBP
monoclonal antibody (1: 100; Millipore) or rabbit poly-
clonal anti-GFAP antibody (1: 800; Millipore), rinsed, and
then incubated for 1 h at room temperature with goat anti-
rat (1:200; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) or anti-rabbit (1:300; Pierce Biotechnology) biotiny-
lated secondary antibodies. Positively-stained cells were
visualized using avidin-biotin-peroxidase complex amplifi-
cation (Pierce Biotechnology) with diaminobenzidine tetra-
hydrochloride detection.
MBP expression was graded in three regions within
the white matter in each hemisphere of each section
using a 4-point scoring system - 0, loss of processes and
complete loss of capsule; 1, loss of processes with thin-
ning or breaks in capsule; 2, complete loss of processes
with intact capsule; 3, partial loss of processes; 4, no
MBP loss - as previously described [14]. The scores of
each region were summed to obtain a total score (range
0 to 12) for each hemisphere. Each section had a total
MBP score in the ipsilateral and contralateral hemi-
sphere, respectively. Observers, blind to the treatment
conditions, assessed the degrees of white matter injury.
Quantitative analysis of immunohistochemical staining
Measurement of MBP scores, the number of ED1 and
cleaved caspase 3-positive cells, and the integrated optical
density (IOD) of p-JNK, TNF-α, IgG and GFAP signals
were respectively analyzed as previously described [41],
using an imaging software (ImagePro Plus 6.0; Media Cy-
bernetics). Measurement was performed at 400× magnifi-
cation per visual field (0.0356 mm2) for cleaved caspase 3-
positive cell numbers, 100× magnification per visual field
(0.579 mm2) for MBP scores, and 200× magnification per
visual field (0.145 mm2) for p-JNK, TNF-α, IgG and GFAP
signals, and ED1-positive cell numbers. Three visual fields
in the medial, middle and lateral areas of the white matter
in each hemisphere per section and four sections per brain
were analyzed and averaged, respectively. The mean IOD
values in the white matter of the ipsilateral and contralat-
eral hemispheres of each experimental group were com-
pared to those of the control group to obtain the relative
IOD ratios.
Immunofluorescent staining
Immunofluorescence was performed at 6 and 24 h post-
insult. After blocking (1× PBS, 2% normal goat serum
and 0.1% Triton X-100) for 1 h, the sections were incu-
bated overnight at 4 °C with a mixture of two of the fol-
lowing primary antibodies: mouse anti-rat ED1 (1:100;
Millipore), mouse monoclonal anti-O4 IgM (1:100;
Millipore), mouse monoclonal anti-rat endothelial cell
antigen-1 (RECA-1; 1:100; Abcam, Cambridge, MA,
USA), rabbit polyclonal anti-p-JNK (1:100; Cell Signal-
ing), mouse monoclonal anti-p-JNK (1:100; Cell
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Signaling), rabbit polyclonal anti-p-c-Jun (1:100; Cell
Signaling), rabbit polyclonal anti-rat TNF-α (1:100;
Bender MedSystems) and rabbit polyclonal anti-cleaved
caspase 3 (1:100; Cell Signaling). The sections were
washed three times with 0.1 M PBS and then incubated
with Alexa Fluor 594 anti-mouse IgG/IgM or Alexa
Fluor 488 anti-rabbit IgG (all 1:400; Invitrogen, Grand
Island, NY, USA) for 1 h at room temperature. Nuclei
were visualized with 4',6-diamidino-2-phenylindole
(DAPI). Slides were photographed for red (Alexa Fluor
594) and green (Alexa Fluor 488) fluorescence with a
fluorescent microscope (E400; Nikon, Tokyo, Japan).
Statistical analysis
Statistical significance (P< 0.05) was determined using
Kruskal-Wallis test, and Dunn’s method was used for
post hoc comparisons. Continuous data were presented
as means ± standard error of the mean (SEM).
Results
Neuroinflammation, blood–brain barrier damage and cell
apoptosis in association with cerebral white matter injury
in rat pups after lipopolysaccharide-sensitized hypoxic-
ischemia
On P11 (9 days post-insult), Nissl staining showed no
significant injury in the cerebral cortex after LPS-
sensitized HI on P2 (Figure 1A). In contrast, significant
white matter injury was found as evidenced by marked
decreases of MBP expression and increases of GFAP
(astrogliosis) in the ipsilateral hemisphere of the LPS +
HI group but not of the NS +HI group (Figure 1B).
Twenty-four hours after injury on P2, the LPS +HI (but
not the NS+HI group) had significant increases of ED1-
positive activated microglia, TNF-α expression, IgG ex-
travasation (BBB damage) and cleaved caspase 3-positive
cells in the white matter compared to the control group
(Figure 1C). These findings suggested upregulation of
neuroinflammation, BBB disruption and cell apoptosis in
the P2 rat pup model of selective white matter injury
induced by LPS +HI.
Early and sustained JNK activation in the microglia,
endothelial cells and oligodendrocyte progenitors of the
white matter after lipopolysaccharide-sensitized hypoxic-
ischemia
Immunoblotting analyses of ipsilateral white matter
demonstrated increased JNK phosphorylation at 24 h
after LPS (Additional file 1: Figure 1D), whereas JNK ac-
tivation occurred early at 1 h, peaked at 6 h and per-
sisted at 24 h post-insult in the LPS +HI group
(Figure 2A). Immunohistochemical analyses confirmed
that the LPS +HI group had increases of p-JNK immu-
noreactivities in the white matter at 6 and 24 h post-
insult compared to the control group (Figure 2B).
Further immunofluorescence studies showed upregu-
lated p-JNK expression in the ED1-positive activated
microglia, RECA-positive vascular endothelial cells and
O4-positive oligodendrocyte progenitors in the white
matter at 6 h (Figure 3A,B,C) and 24 h (Figures 4A, 5A,
B) post-insult. The activated ED1-positive microglia
showed nuclear translocation of p-c-Jun, the down-
stream signal molecule of p-JNK (Figure 4B), and also
highly expressed TNF-α 24 h post-insult (Figure 4C).
Characteristically, there were numerous p-JNK-positive
cells attached to or located around the microvessels in
the white matter (Figure 5A). Furthermore, many of the
p-JNK-positive cells co-expressed cleaved caspase 3
(Figure 5C). Both vascular endothelial cells and oligo-
dendroglial progenitor cells also co-expressed cleaved
caspase 3 (Figure 5D,E), indicating these cells underwent
apoptosis. These findings suggested the involvement of
JNK activation in neuroinflammation, and apoptosis of
endothelial cells and oligodendroglial progenitors in the
white matter after LPS +HI injury.
Pharmacological inhibition of JNK reduced
neuroinflammation, blood–brain barrier damage and cell
apoptosis, and protected against white matter injury after
lipopolysaccharide-sensitized hypoxic-ischemia
We then examined the protective effect of JNK inhibition
on white matter injury using AS601245, an ATP-
competitive inhibitor of JNK. In vitro kinase assay in the
LPS+HI group confirmed that AS601245 (40 mg/kg)
treatment significantly reduced JNK activity compared to
vehicle treatment at 6 and 24 h post-insult (Figure 6A). In
the LPS+HI group, AS601245 treatment significantly
decreased the numbers of ED1-positive activated micro-
glia, TNF-α immunoreactivities, BBB damage and cleaved
caspase 3-positive cells in the white matter 24 h post-
insult compared to vehicle treatment (Figure 6B). Further
immunofluorescent staining showed that AS601245 mark-
edly decreased the p-JNK (+) cells attached to or located
around the microvessels (Figure 7A), and also greatly atte-
nuated cleaved caspase 3 expression in vascular endothe-
lial cells (Figure 7B) and oligodendroglial progenitor cells
(Figure 7C). Compared to vehicle, AS601245 treatment on
P2 at a dosage of 40 mg/kg but not 20 mg/kg in the LPS+
HI group significantly preserved MBP expression
(Figure 8A) and markedly attenuated astrogliosis by
downregulating GFAP immunoreactivities (Figure 8B) in
the white matter on P11.
Genetic knockdown of JNK expression reduced
neuroinflammation, blood–brain barrier disruption and
cell apoptosis, and attenuated white matter injury after
lipopolysaccharide-sensitized hypoxic-ischemia
We next examined the protective effect of JNK inhibition
on white matter injury using JNK antisense ODN.
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Immunoblotting analyses of the white matter tissue of the
LPS+HI group showed that JNK antisense ODN treat-
ment significantly reduced JNK expression at 3, 6 and
12 h post-insult compared to scrambled ODN
(Figure 9A). Antisense ODN treatment significantly
diminished the numbers of ED1-positive activated micro-
glia, TNF-α immunoreactivities, BBB breakdown and
cleaved caspase 3-positive cells in the white matter 24 h
post-insult compared to scrambled ODN treatment
(Figure 9B). Antisense ODN treatment on P2 in the LPS+
Figure 1 Upregulation of neuroinflammation, blood–brain barrier damage and cell apoptosis in association with white matter injury in
P2 rat pups after lipopolysaccharide-sensitized hypoxic-ischemia. On P11 in the LPS +HI group, Nissl staining (A) showed no significant
injury in the cortex (gross picture in the upper panel; microscopic picture in the lower panel photographed from the cortex marked with an
asterisk). (B) Immunohistochemical staining demonstrated that the LPS +HI group had markedly decreased MBP expression and increased GFAP-
positive astrogliosis in the white matter of the ipsilateral hemisphere compared to the control and NS+HI groups. (C) Immunohistochemistry
24 h post-insult showed that the LPS +HI but not the NS+HI group had significant increases in ED1-positive microglia, TNF-α immunoreactivities,
IgG extravasation, and cleaved caspase 3-positive apoptotic cells in the white matter. Microscopic pictures of (B,C) were taken from the white
matter area marked with a circle in (A). ED1, microglia marker; GFAP, glial fibrillary acidic protein; HI, hypoxic-ischemia; LPS, lipopolysaccharide;
MBP, myelin basic protein; NS, normal saline; P, postpartum. Scale bar = 200 μm for MBP, 50 μm for cleaved caspase 3, and 100 μm for the others.
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HI group also increased MBP expression (Figure 10A)
and markedly attenuated astrogliosis (Figure 10B) in the
white matter on P11 compared with scrambled ODN
(Figure 10A,B).
Discussion
White matter injury is the major form of brain injury in
very preterm infants. The O4-positive oligodendrocyte
progenitors, mainly pre-myelinating oligodendrocytes in
P2 rat brain, are the major target cells of damage in the
white matter of very premature infants [12,13]. In this
study, we showed that P2 rat pups had selective white
matter injury (hypomyelination and astrogliosis) on P11
after LPS-sensitized HI. White matter injury in the im-
mature brain was associated with early and sustained
JNK activation in the microglia, vascular endothelial
cells and oligodendrocyte progenitors within 24 h post-
insult, and also with upregulation of microglia activation,
TNF-α expression, BBB leakage, and endothelial cell and
oligodendroglial apoptosis 24 h post-insult. Pharmaco-
logical or genetic inhibition of JNK reduced microglia
activation, TNF-α expression, BBB damage and oligo-
dendrocyte progenitor apoptosis, and protected against
white matter injury after LPS-sensitized HI. These find-
ings suggest that JNK signaling is the shared pathway
linking neuroinflammation, vascular endothelial cell
damage and BBB breakdown, and apoptosis of oligo-
dendroglial precursor cells in the white matter injury of
the immature brain.
Very preterm infants experience various HI and infec-
tious insults during the neonatal period. Infection may
predispose to, or act in concert with, HI in premature
infants. Previous studies show that increased systemic
cytokines in premature infants with chorioamnionitis are
associated with hemodynamic disturbance leading to
cerebral HI [6,7], whereas co-morbid chorioamnionitis
and placental perfusion defect put preterm infants at
higher risk of abnormal neurological outcomes than ei-
ther insult alone [8]. Our previous study using the P2 rat
pup model to mimic brain injury in very preterm infants
demonstrated that selective white matter injury could be
induced by the combination of LPS and HI rather than
by LPS exposure or HI alone [14]. We found that low-
dose LPS upregulated JNK activation in the white matter
without causing tissue damage. In contrast, LPS +HI eli-
cited early and prolonged activation of JNK and resulted
Figure 2 Upregulation of JNK activation in lipopolysaccharide-sensitized hypoxic-ischemic white matter injury. (A) Immunoblotting of
white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed there was an early rise of phospho-c-Jun N-terminal kinase (p-
JNK) expression at 1 h, which peaked at 6 h and persisted at 24 h post-insult. The JNK expression did not differ between the control and LPS +HI
groups at various time points post-insult. (B) p-JNK immunohistochemistry at 6 and 24 h post-insult showed the LPS +HI group (n = 10) had
significantly higher p-JNK immunoreactivities in the white matter of the ipsilateral hemisphere than the control (n = 7) groups. Scale bar =100 μm
in (B). Values are means ± SEM. ***P< 0.001, **P< 0.01.
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in white matter injury. Studies investigating the mechan-
isms of LPS sensitization show early upregulation of
genes associated with stress-induced inflammatory
responses in the immature brain several hours after LPS
exposure [42,43], and the priming effect may contribute
to increased vulnerability of the immature brain to HI
following LPS exposure.
The key features of LPS-sensitized HI white matter in-
jury in the immature brain include: (1) neuroinflamma-
tion, manifested as activation of microglia and
upregulation of TNF-α; (2) vascular endothelial cell dam-
age and BBB breakdown; and (3) apoptosis of O4-positive
oligodendrocyte progenitors [1,2,14]. Although previous
studies have shown that LPS and/or HI induced any one
of the key features of injury in the neonatal rodent brain
[11,40,44], very few studies have examined the three
pathogenic mechanisms as an oligodendrovascular unit in
the white matter, particularly in the immature P2 rat
brain. In the white matter, microglia, vascular endothelial
cells and oligodendrocyte progenitors are closely knitted
together with reciprocal interactions. In physiological
conditions, vascular endothelial cells are the kernel of BBB
and supply oxygen and nutrients from the blood stream to
adjacent brain parenchyma. Both endothelial and various
neural cells can secrete angioneurins to mutually facilitate
vascular and neural development [45]. The survival, prolif-
eration and differentiation of oligodendrocyte progenitors
are regulated by growth factors released from neural cells
[1,46]. During detrimental insults, the activated microglia
may trigger a cascade of reactions, via proinflammatory
cytokines, leading to destroyed BBB damage and cell
apoptosis in the white matter. The damaged microvessels
may further recruit activated leukocytes through the
injured BBB and cause sustained activation of microglia,
which in turn causes further damage in the white matter
[21]. Therefore, to achieve effective therapies for white
matter injury is to protect the entire “oligodendrovascular
unit” through blockade of the common signal transduc-
tion linking neuroinflammation, BBB damage and cell
apoptosis.
Activated microglia play a central role as a converging
point for upstream HI/inflammation and downstream
Figure 3 JNK activation in microglia, vascular endothelial cells and oligodendrocyte progenitors at 6 h post-insult. Immunofluorescence
of the ipsilateral white matter in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed increased phospho-c-Jun N-terminal kinase
(p-JNK) expression in (A) ED1-positive microglia, (B) RECA-positive endothelial cells and (C) O4-positive oligodendrocyte progenitors. Scale
bar = 25 μm. Inset scale bar = 5 μm in (A), 10 μm in (B) and 2.5 μm in (C).
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cytotoxicity in the pathogenesis of white matter injury in
the immature brain [20]. In this study, the findings that
LPS-sensitized HI contributes to JNK activation and the
nuclear translocation of the downstream molecule c-Jun
in the microglia further highlight the neuroinflammatory
role of microglia in the white matter injury. The tran-
scription factor c-Jun subsequently leads to pro-
inflammatory cytokine production, identified in this
study as TNF-α expression in microglia. The increase of
TNF-α immunoreactivities in the white matter corre-
sponds to the region-specific activation of microglia in
this P2 rat pup model of white matter injury. The
microglia-derived TNF-α may not only exert cytotoxic
effects on oligodendrocyte progenitors and endothelial
cells, but also facilitate prolonged microglial activation
via activation of JNK synthesis in an autocrine loop in
the oligodendrovascular unit [47,48].
The BBB acts as a pivotal interface for central- and
peripheral-driven inflammatory processes in brain injury.
In this neonatal rat model, systemic LPS exposure plus
cerebral HI insult triggered BBB disruption and selective
white matter injury. We used extravasation of IgG as an
index of BBB damage. After LPS +HI, the extravascular
IgG immunoreactivity in the white matter could be
observed at the cellular as well as the parenchymal level.
IgG entry into neural cells after brain injury has been
described in studies using immunostaining [49-51]. Glial
cells can rapidly take up plasma proteins from the extra-
cellular space of the injured brain through endocytosis,
and Fc-receptors on reactive microglia can trap IgG in
the tissue and thus facilitate its phagocytic activity
[50,51]. The vulnerability of BBB in the white matter
correlated with the region-specific activation of micro-
glia. JNK-positive activated microglia released TNF-α,
which may contribute to BBB breakdown through upre-
gulation of matrix metalloproteinase-9 [52] or via trig-
gering death signaling in vascular endothelial cells [53].
The cytotoxic effects of TNF-α on endothelial cells may
be mediated directly through formation of a death-
inducing signaling complex or indirectly via JNK activa-
tion [48]. We demonstrated that, after insult, vascular
endothelial cells had both p-JNK and cleaved caspase 3
expression, and p-JNK-positive cells co-expressed
cleaved caspase 3. The findings suggest the role of JNK
Figure 4 Activated microglia expressed p-JNK, p-c-Jun and TNF-α. Immunofluorescence of the ipsilateral white matter in the
lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h post-insult showed that ED1-positive activated microglia expressed phospho-c-Jun N-
terminal kinases (p-JNK) (A) and TNF-α (C), and had nuclear translocation of p-c-Jun (B). Scale bar = 25 μm. Inset scale bar = 5 μm.
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signaling in vascular endothelial cell apoptosis after LPS-
sensitized HI.
A noteworthy finding in this study was that many p-
JNK-positive cells surrounded, or were attached to, the
microvessels in the white matter after insult. These p-
JNK-positive cells may be exogenous leukocytes infiltrat-
ing through the disrupted BBB, or endogenous brain
cells such as microglia. The activated leukocytes may di-
minish the effectiveness of the immature BBB and con-
tribute to sustained BBB disruption by enhancing matrix
metalloproteinase-9 activity [54,55]. In addition, the
leukocytes migrating into the brain may activate micro-
glia, which in turn further damage the BBB and secrete
chemokines to attract more activated leukocytes into the
white matter [21,56]. The BBB disruption by leukocytes
and microglia may also be mediated through JNK/TNF-
α signaling [31,52]. Therefore the increases of BBB per-
meability in the white matter may act in concert with
activated microglia to worsen white matter injury
through leukocyte recruitment into the brain [21].
Oligodendrocyte precursor cells are the end-target of
white matter injury in the oligodendrovascular unit, and
Figure 5 JNK activation-mediated apoptosis in cerebral vascular endothelial cells and oligodendrocyte progenitors in the white matter
after lipopolysaccharide-sensitized hypoxic-ischemia. Immunofluorescence of the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group 24 h
post-insult showed numerous phospho-c-Jun N-terminal kinase (p-JNK)-positive cells attached to or located around the microvessels in the white
matter (A). RECA-positive endothelial cells (A) and O4-positive oligodendrocyte progenitors (B) co-expressed p-JNK. Many p-JNK-positive cells (C),
RECA-positive endothelial cells (D) and O4-positive oligodendrocyte progenitors (E) expressed cleaved caspase 3. Scale bar = 25 μm. Inset scale
bar = 2.5 μm.
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exhibit maturation-dependent vulnerability [1,2,20]. Pre-
myelinating oligodendrocytes display greater susceptibil-
ity to pro-inflammatory cytokines, oxidative damage and
glutamate excitotoxicity than do mature oligodendro-
cytes [1,20]. Our study showed that O4-positive
oligodendrocyte progenitors had sustained JNK activa-
tion after insult, and were the major cells expressing
cleaved caspase 3 apoptotic markers in the white matter.
The co-localization of p-JNK and cleaved caspase 3 in
the white matter further implicated the key role of JNK
Figure 6 AS601245 significantly reduced neuroinflammation, blood–brain-barrier damage and cell apoptosis after lipopolysaccharide-
sensitized hypoxic-ischemic white matter injury. (A) In vitro kinase assay of c-Jun N-terminal kinase (JNK) in the lipopolysaccharide
(LPS) + hypoxic-ischemic (HI) group showed that AS601245 (40 mg/kg) effectively blocked JNK activity at 6 and 24 h post-insult compared with
vehicle. (B) AS601245 (40 mg/kg) treatment (n = 8) significantly reduced upregulation of ED1-positive activated microglia, TNF-α
immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white matter 24 h post-insult compared to vehicle (n = 7). Scale
bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved caspase 3. Values are means ± SEM. ***P <0.001, **P< 0.01, *P< 0.05.
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Figure 7 AS601245 significantly reduced perivascular attachment of p-JNK-positive cells and cell apoptosis in the white matter 24 h
post-insult. Immunofluorescent staining in the lipopolysaccharide (LPS) + hypoxic-ischemic (HI) group showed that, compared with vehicle,
AS601245 (40 mg/kg) significantly attenuated perivascular phospho-c-Jun N-terminal kinase (p-JNK)-positive cell attachment (A), and also
decreased cleaved caspase 3-positive endothelial (B) and oligodendroglial cells (C) in the white matter. Scale bar =25 μm.
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signaling in triggering death events in oligodendrocyte
precursor cells. In addition to cell death, surviving oligo-
dendrocyte progenitors may be deterred from prolifera-
tion and differentiation by microglial activation and
reactive astrocytes [57]. Our findings of reactive astro-
gliosis and hypomyelination on P11 after LPS +HI
reflected the effects of neuroinflammation and impair-
ment of oligodendroglial maturation.
The upstream molecule or signaling pathway that leads
to JNK activation in the oligodendrovascular unit of the
white matter in the very immature brain remains unclear.
Common to both ischemia and inflammation is the pro-
duction of reactive oxygen and nitrogen species (ROS/
RNS), in particular nitric oxide. Nitric oxide production in
excess can be detrimental, particularly in the presence of
ROS, which are known to be associated with oligodendro-
cyte death and white matter injury in preterm infants [58-
61]. Autopsy studies in preterm infants with periventricular
white matter injury have demonstrated protein nitration
and lipid peroxidation in pre-myelinating oligodendrocytes
[60,61]. An animal experiment showed that the free radical
scavenging agent N-acetylcysteine effectively protected
against LPS-sensitized HI brain injury in neonatal rats [11].
These findings suggest a role for ROS/RNS in the patho-
genesis of white matter injury. Studies have also demon-
strated that the synergistic effect of LPS and HI activated
microglia to produce ROS/RNS [11,20], leading to pro-
longed JNK activation which in turn facilitated TNF-α syn-
thesis and more ROS/RNS accumulation in a positive
feedback loop [62,63]. These studies showed that JNK sig-
naling is a key modulator in cell death mediated by ROS/
RNS [63]. Activated microglia may contribute to BBB
breakdown and exert cytotoxicity to endothelial cells and
oligodendrocyte progenitors through both JNK-TNF-α and
ROS/RNS pathways [20,52,59]. The pre-myelinating oligo-
dendrocytes are particularly more vulnerable to oxidative
and nitrosative injury than mature oligodendrocytes due to
impaired antioxidant defenses and susceptibility to glutam-
ate excitotoxicity [1,20]. Exuberant expression of calcium-
permeable glutamate receptors and overexpression of
glutamate transporters in the immature brain give rise to
the maturation-dependent vulnerability of pre-myelinating
oligodendrocytes to glutamate excitotoxicity [1,20]. During
detrimental insults, elevated extracellular glutamate facili-
tates Ca2+ influx through glutamate receptors in oligo-
dendrocyte progenitors, and thus induces ROS/RNS
production which further augments JNK activation-
mediated apoptosis [20,64]. Therefore, LPS-sensitized HI
may damage the oligodendrovascular unit in the immature
brain via a self-potentiating loop of ROS/RNS-JNK-TNF-α
signaling, which leads to sustained microglial activation,
BBB disruption and oligodendroglial apoptosis in a vicious
Figure 8 Pharmacological inhibition of c-Jun N-terminal kinase (JNK) activity using AS601245 significantly attenuated white matter
injury. AS601245 (40 mg/kg) (n = 8) but not AS601245 (20 mg/kg) (n = 8) treatment had significantly higher myelin basic protein (MBP) (A) and
lower glial fibrillary acidic protein (GFAP) (B) expression in the white matter than vehicle (n = 10) on P11 after lipopolysaccharide (LPS)-sensitized
hypoxic-ischemia (HI) on P2. Scale bar = 200 μm in (A), 100 μm in (B). Values are means ± SEM. ***P< 0.001, **P< 0.01, *P< 0.05.
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cycle. Further study is needed to address the role of ROS/
RNS as the upstream mechanism of JNK activation in the
oligodendrovascular unit of the white matter injury of the
immature brain after LPS and HI injury.
Previous studies have shown that JNK inhibitors
exerted neuroprotective effects against focal or global is-
chemic injury in adult rodent models of stroke
[25,27,28,65], and JNK3 knock-out mice were protected
Figure 9 JNK antisense oligodeoxynucleotide significantly reduced neuroinflammation, blood–brain-barrier damage and apoptosis in
the white matter after lipopolysaccharide-sensitized hypoxic-ischemia. (A) Immunoblotting of the white matter showed that
intracerebroventricular infusion of c-Jun N-terminal kinase (JNK) antisense oligodeoxynucleotides (ODN) (n = 3) effectively suppressed JNK
expression compared with scrambled ODN (n = 3) at 3, 6 and 12 h post-insult. (B) Antisense ODN treatment (n = 8) significantly attenuated
upregulation of ED1-positive activated microglia, TNF-α immunoreactivities, IgG extravasation and cleaved caspase 3-positive cells in the white
matter 24 h post-insult compared with scrambled oligodeoxynucleotide (n = 8). Scale bar =100 μm for ED1, TNF-α and IgG; 50 μm for cleaved
caspase 3. Values are means ± SEM. ***P< 0.001, **P< 0.01, *P< 0.05.
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from HI brain injury [26,66]. Using both pharmaco-
logical and genetic approaches, this study demonstrated
that inhibition of JNK activation significantly reduced
neuroinflammation and preserved the oligodendrovascu-
lar unit integrity, and thus protected against white mat-
ter injury after LPS-sensitized HI in the immature brain.
Conclusions
In this P2 rat pup model of selective white matter injury,
JNK signaling was upregulated in the white matter after
LPS-sensitized HI, and acted as the shared pathway inte-
grating neuroinflammation, BBB breakdown and cell
apoptosis in the oligodendrovascular unit. A proposed
diagram (Additional file 2: Figure 2) is provided to show
that in the three major cells within the oligodendrovas-
cular unit - microglia, endothelial cells and oligodendro-
cyte progenitors - JNK and TNF-α may potentiate with
each other in an autocrine or paracrine pattern to aggra-
vate white matter injury. Suppression of JNK activation,
either with the pharmacological inhibitor or by genetic
knockdown of the JNK gene, effectively protected
against LPS-sensitized HI white matter injury in the im-
mature brain. JNK signaling may emerge as a potential
therapeutic target for white matter injury in very pre-
term infants.
Additional files
Additional file 1: Figure 1. Neuropathological examinations in the
lipopolysaccharide (LPS)-treated group on P11 demonstrated no evident
(A) cortical neuronal injury by Nissl staining or (B) white matter injury by
myelin basic protein (MBP) staining. (C) Immunohistochemistry at 24 h
post-insult also did not show significant increases of ED1-positive
microglia and IgG extravasation in the white matter of the LPS-treated
group. (D) Immunoblotting of the white matter showed increased
phosphor-c-Jun N-terminal kinase (p-JNK) expression at 24 h post-LPS.
Scale bar = 200 μm for MBP, and 100 μm for the others.
Additional file 2: Figure 2. A proposed diagram showing the central
role of c-Jun N-terminal kinase (JNK) signaling in the pathogenesis of
lipopolysaccharide (LPS)-sensitized hypoxic-ischemic (HI) white matter
injury in the immature brain. JNK hyperactivation in the
oligodendrovascular unit (microglia, microvascular endothelial cells and
oligodendrocyte progenitors) post-insult may lead to white matter injury
through upregulation of neuroinflammation, blood–brain barrier
disruption and oligodendrocyte progenitor apoptosis.
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